ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 141,758 | $971,042 | 0.18% |
| SAMLYN CAPITAL, LLC | 1,463,074 | $10,022,057 | 0.16% |
| Frazier Life Sciences Management, L.P. | 264,377 | $1,810,982 | 0.12% |
| Corton Capital Inc. | 14,916 | $102,175 | 0.05% |
| Caption Management, LLC | 453,000 | $3,103,050 | 0.05% |
| Perceptive Advisors | 500,000 | $1,450,000 | 0.05% |
| Blackstone Inc. | 1,261,425 | $8,640,761 | 0.04% |
| Atom Investors LP | 22,343 | $153,050 | 0.04% |
| J. Goldman & Co LP | 128,200 | $878,170 | 0.03% |
| Verition Fund Management LLC | 299,685 | $2,052,842 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 37,969 | $260 | 0.02% |
| Trexquant Investment LP | 127,851 | $875,779 | 0.02% |
| Caption Management, LLC | 190,000 | $1,301,500 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 123,500 | $845,975 | 0.02% |
| Caption Management, LLC | 179,400 | $1,228,890 | 0.02% |
| Polar Asset Management Partners Inc. | 125,600 | $860,360 | 0.02% |
| J. Goldman & Co LP | 66,000 | $452,100 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $6,850,000 | 0.02% |
| Assenagon Asset Management S.A. | 687,135 | $4,706,875 | 0.02% |
| ALGERT GLOBAL LLC | 45,120 | $309 | 0.02% |
External links
This page lists ACLARIS THERAPEUTICS INC's shareholders in Q3 2023. To view ACLARIS THERAPEUTICS INC's shareholder history, click here.